Last update 16 May 2026

Teneligliptin Hydrobromide Hydrate/Empagliflozin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HD-P023
Target
DPP-4 x SGLT2
Action
inhibitors
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
Handok, Inc.Handok, Inc.
Active Organization
Handok, Inc.Handok, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC44H65Br5N12O2S2
InChIKeyLUXIOMHUGCXFIU-MAYGPZJUSA-N
CAS Registry906093-29-6
View All Structures (2)

Related

3
Clinical Trials associated with Teneligliptin Hydrobromide Hydrate/Empagliflozin
NCT07102719
/ CompletedPhase 1
A Randomized, Open-label, Crossover, Phase 1 Study to Evaluate Pharmacokinetics and Safety of HD-P023 in Comparison With Coadministration of Teneligliptin and Empagliflozin High in Healthy Volunteers
NCT06889350
/ CompletedPhase 1
A Randomized, Open-label, Crossover, Phase 1 Study to Evaluate Pharmacokinetics and Safety of HD-P023 in Comparison With Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
NCT06339788
/ CompletedPhase 1
A Randomized, Open-label, Crossover, Phase 1 Study to Evaluate Pharmacokinetics and Safety of HD-P023 in Comparison With Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
100 Clinical Results associated with Teneligliptin Hydrobromide Hydrate/Empagliflozin
Login to view more data
100 Translational Medicine associated with Teneligliptin Hydrobromide Hydrate/Empagliflozin
Login to view more data
100 Patents (Medical) associated with Teneligliptin Hydrobromide Hydrate/Empagliflozin
Login to view more data
100 Deals associated with Teneligliptin Hydrobromide Hydrate/Empagliflozin
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free